Date	Period	Revenue/Estimate	Earnings Call
Feb 9, 2024	2023/FY	427.000M / --	--
Feb 13, 2023	2022/FY	411.000M / --	--
Feb 10, 2022	2021/FY	412.000M / --	--
--	2020/FY	334.000M / --	--
Feb 13, 2020	2019/FY	549.000M / --	--

DatePeriodRevenue/EstimateEarnings Call

Feb 9, 20242023/FY427.000M / ----

Feb 13, 20232022/FY411.000M / ----

Feb 10, 20222021/FY412.000M / ----

--2020/FY334.000M / ----

Feb 13, 20202019/FY549.000M / ----

Unlock Free Earnings Estimates

Open Account

D. Western Therapeutics Institute Earnings Reports

D. Western Therapeutics Institute: Extraordinary Report

Jan 16 01:34 ET

D. Western Therapeutics Institute: Notice regarding revisions to earnings forecasts (consolidated/individual) and recording of extraordinary losses (individual)

Jan 16 01:30 ET

D. Western Therapeutics Institute: Extraordinary Report

Jan 9 20:55 ET

D. Western Therapeutics Institute: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (consolidated)

Nov 14, 2024 01:30 ET

Symbol Price % Chg